Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Gene record

ADCY1

adenylate cyclase 1

translation score 0.74, read 2026-10-17; 1 sealed predictions, 0 held; 1 receipts.

Six readers

readerfoundscore
genetics
Open Targets
genetic association 0.53 (overall 0.33)0.53
cell type
Human Protein Atlas
cell type enhanced, including brain excitatory neurons; strongest in cone photoreceptor cells0.75
chemistry
Open Targets
a small-molecule pocket0.60
trials
ClinicalTrials.gov
no Parkinson's trials on record: an open field1.00
literature
PubMed
1 Parkinson's papers of 1520.91
pathways
Reactome
15 pathways; mostly immune signalling0.90
proposal for ADCY1, translation score 0.74

Knock down and overexpress ADCY1 in dopamine neurons; measure IL-1β and TNF release and surface HLA-DR and survival of TH-positive neurons and phospho-α-synuclein (pS129) inclusions after seeding with α-synuclein fibrils.

Cell type
dopamine neurons
Direction
Both arms: public data does not say which way helps.
Molecular readout
IL-1β and TNF release and surface HLA-DR
Functional readout
survival of TH-positive neurons and phospho-α-synuclein (pS129) inclusions after seeding with α-synuclein fibrils
Rule-out
If neither arm moves IL-1β by 20% or more against non-targeting and empty-vector controls, across three independent differentiations, the hypothesis is wrong.
Lab request
CRISPRi knockdown and lentiviral overexpression of ADCY1 in iPSC-derived midbrain dopamine neurons (FOXA2+, LMX1A+, TH+); n = 3 differentiations; readouts: IL-1β and TNF release and surface HLA-DR; survival of TH-positive neurons and phospho-α-synuclein (pS129) inclusions after seeding with α-synuclein fibrils. Controls: non-targeting guide, empty vector. About 8 to 10 weeks, most of it differentiation.

Sealed predictions

  1. ADCY1 in dopamine neurons, braak-0.45 (p 0.219) → -0.49 (p 0.177)receipt 1006

Swarm cases

receipt 1006: ADCY1 in dopamine neurons, braak

power
full sample -0.40 (p 0.097, n 18), 95% CI -0.73 to +0.08. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.40 (p 0.097, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.64 (p 0.0039, n 18). not the mix.
skeptic
leave-one-out range -0.53 to -0.33, sign flips 0; without severely affected donors -0.40 (p 0.097, n 18). robust.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for ADCY1 in dopamine neurons.

case closed: nothing better to follow up.

Receipts

loading the receipts